Moneycontrol PRO
HomeNewsCapitalfirst

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Buy SAIL, Capital First may hit Rs 439: Rajat Bose

    Rajat Bose of rajatkbose.com recommends buying SAIL at current level and feels that Capital First may hit Rs 439.

  • Capital First may move to Rs 468: Daljeet Singh Kohli

    Capital First may move to Rs 468: Daljeet Singh Kohli

    Daljeet Singh Kohli, Head of Research at India Nivesh Securities feels that Capital First may move to Rs 468.

  • Prefer Aurobindo Pharma, Mindtree, SKS Micro: Dipan Mehta

    Prefer Aurobindo Pharma, Mindtree, SKS Micro: Dipan Mehta

    Dipan Mehta, Member at BSE & NSE is of the view that one may prefer Aurobindo Pharma, Cadila Healthcare and Torrent Pharmaceuticals from pharmaceutical space.

  • Samvat 2072: Top Diwali portfolio picks by Dipan Mehta

    Samvat 2072: Top Diwali portfolio picks by Dipan Mehta

    Dipan Mehta, Member at BSE & NSE is of the view that one can add selective banks, auto, pharma and FMCG stocks in the portfolio.

  • Bull's Eye: Buy LIC Housing, Just Dial, JSPL, Canara Bank

    Bull's Eye: Buy LIC Housing, Just Dial, JSPL, Canara Bank

    Dharmesh Kant of India Nivesh Securities is of the view that one may buy LIC Housing Finance with a target of Rs 490.

  • Bull's Eye: Buy Titan, PTC India, Exide, Rel Infra, Sun TV

    Bull's Eye: Buy Titan, PTC India, Exide, Rel Infra, Sun TV

    Gaurav Ratnaparkhi of Sharekhan advises buying Sun TV with a target of Rs 339.

  • Bull's Eye: Buy NTPC, Cipla, Rolta, sell Reliance Infra

    Bull's Eye: Buy NTPC, Cipla, Rolta, sell Reliance Infra

    Rakesh Bansal of RK Global suggets buying Gruh Finance with a target of Rs 258.

  • Bull's Eye: PTC India, Bharat Forge, KPIT, NBCC, Wockhardt

    Bull's Eye: PTC India, Bharat Forge, KPIT, NBCC, Wockhardt

    Dharmesh Kant of India Nivesh Securities is of the view that one may buy Sintex Industries with a target of Rs 124.

  • Capital First may move to Rs 400: Daljeet Kohli

    Capital First may move to Rs 400: Daljeet Kohli

    According to Daljeet S Kohli, Head of Research at Indianivesh Securities, Capital First may move to Rs 400.

  • Buy Capital First, LIC Housing, DCB Bank: Dharmesh Kant

    Buy Capital First, LIC Housing, DCB Bank: Dharmesh Kant

    Dharmesh Kant of India Nivesh Securities recommends buying DCB Bank with a target at Rs 120 and Sintex Industries with a target at Rs 100.

  • Bull's Eye: Buy LIC Housing, Sintex, DCB Bank, Petronet LNG

    Bull's Eye: Buy LIC Housing, Sintex, DCB Bank, Petronet LNG

    Dharmesh Kant of India Nivesh Securities recommends buying Capital First with a target at Rs 370 and DCB Bank with a target at Rs 120.

  • Prefer Bajaj Finance, SKS Microfinance, Emami: Dipan Mehta

    Prefer Bajaj Finance, SKS Microfinance, Emami: Dipan Mehta

    Dipan Mehta, Member at BSE & NSE is of the view that one may prefer Bajaj Finance, SKS Microfinance, Emami and Jyothy Laboratories.

  • Bull's Eye: Buy Canara Bank, Sintex, SKS, Sharda Cropchem

    Bull's Eye: Buy Canara Bank, Sintex, SKS, Sharda Cropchem

    Dharmesh Kant, India Nivesh Securities advises buying Ahmednagar Forgings for a target price of Rs 430 and Canara Bank for a target price of Rs 420.

  • Buy Cadila Health, Canara Bk, Capital First: Dharmesh Kant

    Buy Cadila Health, Canara Bk, Capital First: Dharmesh Kant

    Dharmesh Kant of India Nivesh Securities is of the view that one can buy Capital First for a target price of Rs 330 and Canara Bank for a target price of Rs 390.

  • Bull's Eye: Buy BHEL, NTPC, REC, Ahmednagar Forgings

    Bull's Eye: Buy BHEL, NTPC, REC, Ahmednagar Forgings

    Dharmesh Kant, India Nivesh Securities advises buying Ahmednagar Forgings for a target price of Rs 430 and Cadila Healthcare for a target price of Rs 1,460.

  • Prefer Capital First: Daljeet Singh Kohli

    Prefer Capital First: Daljeet Singh Kohli

    Daljeet Singh Kohli, Head of Research at Indianivesh is of the view that one may prefer Capital First.

  • Buy SKS Micro, Capital First; sell Rel Infra: Dharmesh Kant

    Buy SKS Micro, Capital First; sell Rel Infra: Dharmesh Kant

    Dharmesh Kant of IndiaNivesh Securities is of the view that one can buy SKS Microfinance for a target of Rs 360 and sell Reliance Infrastructure for a target of Rs 670.

  • Bull's Eye: Buy Biocon, SKS Microfinance, Igarashi Motor

    Bull's Eye: Buy Biocon, SKS Microfinance, Igarashi Motor

    Manav Chopra, Nirmal Bang advises buying Biocon for a target price of Rs 530 and CESC for a target price of Rs 790.

  • Exit from Future Capital, says SP Tulsian

    Exit from Future Capital, says SP Tulsian

    SP Tulsian, sptulsian.com advice traders to exit from Future Capital at current levels.

  • Exit Future Capital: Rajesh Agarwal

    Exit Future Capital: Rajesh Agarwal

    Rajesh Agarwal, Eastern Financiers is of the view that one should exit Future Capital Holdings.

  • Future Capital looks good, says Sukhani

    Future Capital looks good, says Sukhani

    Future Capital is looking good, says Sudarshan Sukhani of s2analytics.com.

  • Bull's Eye: Short SAIL, IDBI Bank; buy Tata Motors

    Bull's Eye: Short SAIL, IDBI Bank; buy Tata Motors

    CNBC-TV18 brings you a brand new week of Bull's Eye. It's the popular game show where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Future Capital may test Rs 145, says SP Tulsian

    Future Capital may test Rs 145, says SP Tulsian

    Future Capital may test Rs 145, says SP Tulsian, sptulsian.com.

  • Bandyopadhyay`s view on Tata Motors, Future Capital

    Bandyopadhyay`s view on Tata Motors, Future Capital

    Sudip Bandyopadhyay, MD & CEO, Destimoney Securities shares his view on Tata Motors and Future Capital.

  • Bull's Eye: Buy BHEL, Zee Entertainment, TV Today, Lovable

    Bull's Eye: Buy BHEL, Zee Entertainment, TV Today, Lovable

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347